These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 26772531)

  • 1. AMPK in cardiac fibrosis and repair: Actions beyond metabolic regulation.
    Daskalopoulos EP; Dufeys C; Bertrand L; Beauloye C; Horman S
    J Mol Cell Cardiol; 2016 Feb; 91():188-200. PubMed ID: 26772531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldolase promotes the development of cardiac hypertrophy by targeting AMPK signaling.
    Li Y; Zhang D; Kong L; Shi H; Tian X; Gao L; Liu Y; Wu L; Du B; Huang Z; Liang C; Wang Z; Yao R; Zhang Y
    Exp Cell Res; 2018 Sep; 370(1):78-86. PubMed ID: 29902536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMPK in Cardiovascular Diseases.
    Daskalopoulos EP; Dufeys C; Beauloye C; Bertrand L; Horman S
    Exp Suppl; 2016; 107():179-201. PubMed ID: 27812981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMPK and cardiac remodelling.
    Feng Y; Zhang Y; Xiao H
    Sci China Life Sci; 2018 Jan; 61(1):14-23. PubMed ID: 29170891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced scar maturation and contractility lead to exaggerated left ventricular dilation after myocardial infarction in mice lacking AMPKα1.
    Noppe G; Dufeys C; Buchlin P; Marquet N; Castanares-Zapatero D; Balteau M; Hermida N; Bouzin C; Esfahani H; Viollet B; Bertrand L; Balligand JL; Vanoverschelde JL; Beauloye C; Horman S
    J Mol Cell Cardiol; 2014 Sep; 74():32-43. PubMed ID: 24805196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient activation of AMPK preceding left ventricular pressure overload reduces adverse remodeling and preserves left ventricular function.
    Nam DH; Kim E; Benham A; Park HK; Soibam B; Taffet GE; Kaelber JT; Suh JH; Taegtmeyer H; Entman ML; Reineke EL
    FASEB J; 2019 Jan; 33(1):711-721. PubMed ID: 30024790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berberine treatment prevents cardiac dysfunction and remodeling through activation of 5'-adenosine monophosphate-activated protein kinase in type 2 diabetic rats and in palmitate-induced hypertrophic H9c2 cells.
    Chang W; Zhang M; Meng Z; Yu Y; Yao F; Hatch GM; Chen L
    Eur J Pharmacol; 2015 Dec; 769():55-63. PubMed ID: 26522928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the atypical protein kinase Czeta in regulation of 5'-AMP-activated protein kinase in cardiac and skeletal muscle.
    Ussher JR; Jaswal JS; Wagg CS; Armstrong HE; Lopaschuk DG; Keung W; Lopaschuk GD
    Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E349-57. PubMed ID: 19625676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy.
    Li HL; Yin R; Chen D; Liu D; Wang D; Yang Q; Dong YG
    J Cell Biochem; 2007 Apr; 100(5):1086-99. PubMed ID: 17266062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studying the Role of AMPK in Cardiac Hypertrophy and Protein Synthesis.
    Mailleux F; Beauloye C; Balligand JL; Horman S; Bertrand L
    Methods Mol Biol; 2018; 1732():321-342. PubMed ID: 29480485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity.
    Timm KN; Tyler DJ
    Cardiovasc Drugs Ther; 2020 Apr; 34(2):255-269. PubMed ID: 32034646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation.
    Gélinas R; Mailleux F; Dontaine J; Bultot L; Demeulder B; Ginion A; Daskalopoulos EP; Esfahani H; Dubois-Deruy E; Lauzier B; Gauthier C; Olson AK; Bouchard B; Des Rosiers C; Viollet B; Sakamoto K; Balligand JL; Vanoverschelde JL; Beauloye C; Horman S; Bertrand L
    Nat Commun; 2018 Jan; 9(1):374. PubMed ID: 29371602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.
    Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K
    J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMP-activated protein kinase sparks the fire of cardioprotection against myocardial ischemia and cardiac ageing.
    Gu C; Li T; Jiang S; Yang Z; Lv J; Yi W; Yang Y; Fang M
    Ageing Res Rev; 2018 Nov; 47():168-175. PubMed ID: 30110651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMP-activated protein kinase in the control of cardiac metabolism and remodeling.
    Horman S; Beauloye C; Vanoverschelde JL; Bertrand L
    Curr Heart Fail Rep; 2012 Sep; 9(3):164-73. PubMed ID: 22767403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease.
    Wong AK; Howie J; Petrie JR; Lang CC
    Clin Sci (Lond); 2009 Apr; 116(8):607-20. PubMed ID: 19275766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear AMPK regulated CARM1 stabilization impacts autophagy in aged heart.
    Li C; Yu L; Xue H; Yang Z; Yin Y; Zhang B; Chen M; Ma H
    Biochem Biophys Res Commun; 2017 Apr; 486(2):398-405. PubMed ID: 28315332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy.
    Kim J; Wende AR; Sena S; Theobald HA; Soto J; Sloan C; Wayment BE; Litwin SE; Holzenberger M; LeRoith D; Abel ED
    Mol Endocrinol; 2008 Nov; 22(11):2531-43. PubMed ID: 18801929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMPK activation enhances PPARα activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway.
    Meng R; Pei Z; Zhang A; Zhou Y; Cai X; Chen B; Liu G; Mai W; Wei J; Dong Y
    Arch Biochem Biophys; 2011 Jul; 511(1-2):1-7. PubMed ID: 21530483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A-kinase anchoring proteins: molecular regulators of the cardiac stress response.
    Diviani D; Maric D; Pérez López I; Cavin S; Del Vescovo CD
    Biochim Biophys Acta; 2013 Apr; 1833(4):901-8. PubMed ID: 22889610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.